6976.TWO
Price:
$16.6
Market Cap:
$9.65B
Acepodia, Inc. operates as a clinical stage biotechnology company. The company engages in developing cell therapies with its unique antibody cell conjugation (ACC) platform technology to address gaps in cancer care. It links tumor targeting antibodies to its proprietary immune cells, such as gamma delta 2 T cells to create novel ACE therapies. The company was founded in 2017 and is headquartered in Grand Cayman, the Cayman Islands.
Industry
Biotechnology
IPO Date
2023-08-08
Stock Exchange
TWO
Ticker
6976.TWO
According to Acepodia, Inc.’s latest financial reports and current stock price. The company's current ROE is -11.14%. This represents a change of 160.94% compared to the average of -4.27% of the last 4 quarters.
The mean historical ROE of Acepodia, Inc. over the last ten years is 30.09%. The current -11.14% ROE has changed -137.01% with respect to the historical average. Over the past ten years (40 quarters), 6976.TWO's ROE was at its highest in in the December 2022 quarter at 49.57%. The ROE was at its lowest in in the June 2023 quarter at -9.29%.
Average
30.09%
Median
46.98%
Minimum
-12.70%
Maximum
64.06%
Discovering the peaks and valleys of Acepodia, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 0%
Maximum Annual ROE = 64.06%
Minimum Annual Increase = -127.04%
Minimum Annual ROE = -12.70%
| Year | ROE | Change |
|---|---|---|
| 2024 | -7.84% | -38.32% |
| 2023 | -12.70% | -127.04% |
| 2022 | 46.98% | -21.67% |
| 2021 | 59.98% | -6.37% |
The current ROE of Acepodia, Inc. (6976.TWO) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
8.81%
5-year avg
30.09%
10-year avg
30.09%
Acepodia, Inc.’s ROE is greater than AP Biosciences Inc (-25.56%), less than PharmaEngine, Inc. (33.38%), greater than Medeon Biodesign, Inc. (-52.70%), greater than Mycenax Biotech Inc. (-25.50%), greater than Adimmune Corporation (-4.48%), greater than CHO Pharma, Inc. (-8.57%), greater than Pharmosa Biopharm Inc. (-15.24%), greater than OBI Pharma, Inc. (-79.60%), greater than TaiGen Biopharmaceuticals Holdings Limited (-22.99%), greater than Medigen Vaccine Biologics Corporation (-3.74%),
| Company | ROE | Market cap |
|---|---|---|
| -25.56% | $12.68B | |
| 33.38% | $10.36B | |
| -52.70% | $8.57B | |
| -25.50% | $6.72B | |
| -4.48% | $8.11B | |
| -8.57% | $6.42B | |
| -15.24% | $6.92B | |
| -79.60% | $7.59B | |
| -22.99% | $7.90B | |
| -3.74% | $13.03B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Acepodia, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Acepodia, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Acepodia, Inc.'s ROE?
How is the ROE calculated for Acepodia, Inc. (6976.TWO)?
What is the highest ROE for Acepodia, Inc. (6976.TWO)?
What is the 3-year average ROE for Acepodia, Inc. (6976.TWO)?
What is the 5-year average ROE for Acepodia, Inc. (6976.TWO)?
How does the current ROE for Acepodia, Inc. (6976.TWO) compare to its historical average?